Novo Nordisk CEO Mike Doustdar discusses the company’s strategic AI partnership with AWS to accelerate drug discovery with Cheryl Casone on Mornings with Maria.
Novo Nordisk President and CEO Mike Doustdar announces the company’s strategic AI partnership with Amazon Web Services to accelerate drug discovery during an interview with Cheryl Casone on Mornings with Maria. Doustdar explains how artificial intelligence can potentially reduce the typical fifteen-year medicine development timeline to just five years, supercharging scientific researchers to find cures faster.
Read the full article here